Billing and Coding: Treatment of Males with Low Testosterone

Policy A57615 provides billing and coding guidance for treatment of males with low testosterone and explicitly directs users to apply this guidance together with the associated Local Coverage Determination (LCD). The document itself does not specify clinical indications, exclusions, documentation forms, or frequency limits — consult the associated LCD for the actual coverage criteria.

"This billing and coding guidance must be used in conjunction with the associated Local Coverage Determination (LCD)."

Sign up to see full coverage criteria, indications, and limitations.